Funding Opportunities

New Funding Opportunities

See the Events page for webinars and technical assistance videocasts on applying to certain Funding Opportunity Announcements.

Notice Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-018
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Notice Number RFA-NS-19-016
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Notice Number RFA-NS-19-017
Post Date December 10, 2018
Expiration Date February 22, 2021
Notice Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
Notice Number RFA-EB-18-003
Post Date December 10, 2018
Expiration Date February 23, 2021
Notice America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)
Notice Number RFA-DA-19-019
Post Date December 10, 2018
Expiration Date September 9, 2021
Notice Announcement of the NCATS ASPIRE Design Challenges to Develop Innovative and Catalytic Approaches Towards Solving the Opioid Crisis
Notice Number NOT-TR-18-031
Post Date December 10, 2018
Expiration Date N/A
Notice America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)
Notice Number RFA-DA-19-020
Post Date December 10, 2018
Expiration Date September 9, 2021
Notice Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16–30)
Notice Number NOT-DA-19-003
Post Date December 10, 2018
Expiration Date N/A
Notice Notice of Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
Notice Number NOT-NS-19-014
Post Date December 10, 2018
Expiration Date N/A
Notice Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed)
Notice Number RFA-NS-19-020
Post Date December 10, 2018
Expiration Date June 5, 2019
Notice Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)
Notice Number RFA-NS-19-010
Post Date November 5, 2018
Expiration Date June 5, 2019
Notice Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-046
Post Date September 19, 2018
Expiration Date March 13, 2020
Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-043
Post Date September 19, 2018
Expiration Date November 13, 2019
Notice Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
Notice Number RFA-NS-18-042
Post Date September 19, 2018
Expiration Date November 13, 2019
Notice Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Notice Number RFA-NS-18-041
Post Date August 2, 2018
Expiration Date March 13, 2020
Notice Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
Notice Number RFA-DA-19-002
Post Date December 14, 2017
Expiration Date January 2, 2020
Notice NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
ID Number RFA-DA-18-020
Post Date December 6, 2017
Expiration Date September 8, 2020
Notice Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Notice Number PAR-18-219
Post Date November 21, 2017
Expiration Date July 26, 2019
Notice Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
Notice Number PAR-18-218
Post Date November 21, 2017
Expiration Date July 26, 2019

Funded Projects

Opioid Addiction and Overdose Medications

Project Title Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3)
Awardees
Funding Opportunity Announcement RFA-DA-19-002
Summary Support the discovery and development of medications to prevent and treat opioid use disorders (OUD) and overdose.
Project Title Prescription Drug Abuse (R01 Clinical Trial Optional)
Awardee McLean Hospital
Funding Opportunity Announcement PA-18-058
Summary Reduce the side effect and abuse liability profiles of opioid drugs.
Project Title Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional)
Awardees
Funding Opportunity Announcement PA-18-055
Summary Development and test behavioral and integrative treatments for drug and alcohol abuse and dependence.
Project Title Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Awardee Biomedical Research Institute of New Mexico
Funding Opportunity Announcement PAR-18-219
Summary Synthesize and test novel drug candidates for progression to new human anti-addiction pharmacotherapies for substance use disorders.
Project Title NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Awardee Wayne State University
Funding Opportunity Announcement PA-18-344
Summary This broad funding opportunity announcement supports the early and conceptual stages of research projects.
Project Title NIH Research Project Grant (Parent R01 Clinical Trial Required)
Awardee Yale University
Funding Opportunity Announcement PA-18-345
Summary Supports research projects proposing mechanistic studies that meet NIH's definition of a clinical trial as related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Project Title NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Awardee University of Texas Health Science Center
Funding Opportunity Announcement PA-18-484
Summary Supports research projects related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Project Title NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Awardee Purdue University
Funding Opportunity Announcement PA-18-489
Summary This broad funding opportunity announcement supports the early and conceptual stages of research projects.
Project Title PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Awardee

Avior, Inc.

Funding Opportunity Announcement PA-18-574
Summary This broad funding opportunity announcement supports small business concerns that have the research capabilities and technological expertise to contribute to the R&D missions of NIH, CDC, and FDA.
Project Type New Projects within Current Research
Awardees
Summary This supplement supports research to expand therapeutic options for addiction, overdose prevention and reversal.

Implementation Science for Preventing and Treating Addiction

Project Title HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Data Coordinating Center) (UM1- Clinical Trials Not Allowed)
Awardee Research Triangle Institute
Funding Opportunity Announcement RFA-DA-19-017
Summary Serve as the study’s coordinating center and responsible for data analysis, health economics research, and widespread dissemination of research findings.
Project Type New Projects within Current Research
Awardees
Summary These supplements support implementation science research efforts to test the integration of evidence-based interventions in an array of settings.

Addiction Prevention and Treatment

Project Title Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
Awardee University of Washington
Funding Opportunity Announcement RFA-AT-18-001
Summary Examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD.
Project Title Clinical Trials or Observational Studies of Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
Awardees
Funding Opportunity Announcement RFA-AT-18-002
Summary Test approaches using behavioral interventions for primary or secondary prevention of opioid use disorder (OUD) or as an adjunct to medication assisted treatment for OUD.
Project Title Development of a Device to Objectively Measure Pain (R43/R44)
Awardee Affinergy, LLC
Funding Opportunity Announcement RFA-DA-18-012
Summary Develop a technology/device that objectively indicates the presence and level of pain
Project Title Mentored Research Scientist Development Award (Parent K01)
Awardee

University of Michigan Ann Arbor

Funding Opportunity Announcement PA-16-190
Summary Support an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence.
Project Title PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Awardee Blue Therapeutics, Inc.
Funding Opportunity Announcement PA-17-032
Summary This broad funding opportunity announcement supports small business concerns that have the research capabilities and technological expertise to contribute to the R&D missions of NIH, CDC, and FDA.
Project Title PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Awardee

Sober Grid

Funding Opportunity Announcement PA-18-573
Summary This broad funding opportunity announcement supports small business concerns that have the research capabilities and technological expertise to contribute to the R&D mission of NIH and propose a clinical trial project that is related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Project Title PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Awardees
Funding Opportunity Announcement PA-18-574
Summary This broad funding opportunity announcement supports small business concerns that have the research capabilities and technological expertise to contribute to the R&D missions of NIH, CDC, and FDA.
Project Title PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
Awardees Beacon Technologies
Funding Opportunity Announcement PA-18-575
Summary This broad funding opportunity announcement supports small business concerns that have the research capabilities and technological expertise to contribute to the R&D mission of NIH.
Project Type New Projects within Current Research
Awardees
Summary These supplements support research to develop therapies to treat opioid use disorder and prevent and reverse overdose.

Preclinical Research on Pain

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to accelerate the discovery and preclinical development of new medication and device treatments for pain.

Clinical Trials on Pain Management

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to understand the biological underpinnings of chronic pain, identify new biomarkers for pain, and create a clinical trials network for testing new pain therapies.

Improving Outcomes in Infants and Children Exposed to Opioids

Project Type New Projects within Current Research
Awardees
Summary These supplements support research to improve short- and long-term developmental outcomes in children exposed to opioids.

This page last reviewed on April 18, 2019